Filing Details
- Accession Number:
- 0001209191-15-075617
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-10-15 20:25:49
- Reporting Period:
- 2015-10-15
- Filing Date:
- 2015-10-15
- Accepted Time:
- 2015-10-15 20:25:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1394319 | Tracon Pharmaceuticals Inc. | TCON | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1590442 | Partnership Limited Investment V3 Super Jafco | Otemachi First Square, West Tower 11F 1-5-1 Otemachi, Chiyoda-Ku Tokyo M0 100-0004 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-10-15 | 5,300 | $10.16 | 1,498,553 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $10.00 to $10.35. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.